Mass spectrometry (MS)

Definition

Mass spectrometry is a powerful analytical technique that ionizes chemical compounds and measures the mass-to-charge ratio (m/z) of the resulting ions. A mass spectrometer consists of an ionization source (which converts neutral molecules into charged particles), a mass analyzer (which separates ions based on their m/z), and a detector (which records the abundance of each m/z value). The resulting mass spectrum shows peaks at specific m/z values, each corresponding to a molecular ion or fragment ion with a particular mass. For peptides, mass spectrometry provides several critical pieces of information: the molecular weight of the peptide (determining if it matches the expected structure), the identity of the peptide (through pattern matching with databases or standards), and the presence of contaminants or degradation products with different masses. Liquid chromatography coupled with mass spectrometry (LC-MS) combines HPLC separation with mass spectrometric detection, providing both the separation power of HPLC and the identification power of MS.

Different ionization techniques suit different compound types. Electrospray ionization (ESI) is commonly used for peptides because it produces multiply charged ions, allowing mass spectrometers to measure peptides accurately. Matrix-assisted laser desorption/ionization (MALDI) is another technique used for peptide analysis. The type of mass analyzer used (quadrupole, time-of-flight, Orbitrap) affects resolution, accuracy, and sensitivity. High-resolution mass spectrometry can measure molecular weights to extraordinary precision (within parts per million), confirming peptide identity and detecting subtle structural variations.

In quality control, mass spectrometry serves complementary roles to HPLC. While HPLC determines the percentage of the target peptide (purity), mass spectrometry confirms the molecular identity and can characterize the structure of any impurities detected. LC-MS is the gold standard for comprehensive peptide characterization in both research and regulatory contexts. Regulatory submissions for new peptide drugs typically include extensive LC-MS data supporting the identity, purity, and stability of the active pharmaceutical ingredient.